Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$384M |
| 2 |
Mondelez International
MDLZ
|
+$125M |
| 3 |
NVIDIA
NVDA
|
+$116M |
| 4 |
Johnson & Johnson
JNJ
|
+$105M |
| 5 |
Church & Dwight Co
CHD
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$276M |
| 2 |
Apple
AAPL
|
+$180M |
| 3 |
Duke Energy
DUK
|
+$75.7M |
| 4 |
ConocoPhillips
COP
|
+$73.6M |
| 5 |
Broadcom
AVGO
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 9.83% |
| 3 | Utilities | 6.25% |
| 4 | Real Estate | 4.8% |
| 5 | Consumer Discretionary | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Popular Inc
BPOP
$10.7B
| $661K | ﹤0.01% |
+6,594
| New | +$642K |
|
1102
Cytek Biosciences
CTKB
$577M
| $661K | ﹤0.01% |
119,242
+82,208
| +222% | +$466K |
|
1103
HealthStream
HSTM
$842M
| $655K | ﹤0.01% |
22,727
-25,320
| -53% | -$725K |
|
1104
Yum! Brands
YUM
$42.9B
| $651K | ﹤0.01% |
+4,662
| New | +$620K |
|
1105
Brown-Forman Class A
BF.A
$13.5B
| $650K | ﹤0.01% |
+13,514
| New | +$611K |
|
|
RVNC
1106
DELISTED
Revance Therapeutics, Inc.
RVNC
| $649K | ﹤0.01% |
125,000
-316,584
| -72% | -$1.57M |
|
1107
Heritage Financial
HFWA
$1.19B
| $648K | ﹤0.01% |
29,744
-15,633
| -34% | -$333K |
|
1108
Telos
TLS
$327M
| $647K | ﹤0.01% |
180,341
+151,588
| +527% | +$542K |
|
1109
PUT
Verizon
VZ
$208B
| $647K | ﹤0.01% |
14,400
-49,100
| -77% | -$2.05M |
|
1110
CION Investment
CION
$363M
| $644K | ﹤0.01% |
54,111
-70,389
| -57% | -$849K |
|
|
BAND
1111
Bandwidth Inc
BAND
$1.49B
| $642K | ﹤0.01% |
+36,685
| New | +$650K |
|
1112
Option Care Health
OPCH
$3.55B
| $641K | ﹤0.01% |
+20,470
| New | +$628K |
|
1113
Credo Technology Group
CRDO
$41.5B
| $639K | ﹤0.01% |
+20,734
| New | +$618K |
|
|
SII
1114
Sprott
SII
$3.49B
| $635K | ﹤0.01% |
+14,662
| New | +$620K |
|
1115
CALL
Enphase Energy
ENPH
$4.91B
| $633K | ﹤0.01% |
5,600
-30,000
| -84% | -$3.35M |
|
|
FFWM
1116
DELISTED
First Foundation Inc
FFWM
| $628K | ﹤0.01% |
+100,562
| New | +$643K |
|
1117
Unifirst Corp
UNF
$5.28B
| $626K | ﹤0.01% |
3,149
-13,860
| -81% | -$2.55M |
|
1118
Pulmonx
LUNG
$97.9M
| $624K | ﹤0.01% |
75,246
+26,694
| +55% | +$193K |
|
1119
NET Power
NPWR
$176M
| $624K | ﹤0.01% |
+89,025
| New | +$748K |
|
1120
Consolidated Water Co
CWCO
$479M
| $623K | ﹤0.01% |
24,702
+10,664
| +76% | +$285K |
|
1121
PUT
Procter & Gamble
PG
$341B
| $623K | ﹤0.01% |
+3,600
| New | +$611K |
|
1122
Radware
RDWR
$1.16B
| $622K | ﹤0.01% |
27,914
-74,241
| -73% | -$1.53M |
|
|
BLD
1123
DELISTED
TopBuild
BLD
| $619K | ﹤0.01% |
+1,521
| New | +$614K |
|
1124
Leslie's
LESL
$5.44M
| $619K | ﹤0.01% |
+9,800
| New | +$604K |
|
1125
Marcus Corp
MCS
$953M
| $617K | ﹤0.01% |
40,946
-44,304
| -52% | -$584K |
|
Similar funds
Michael Gelband's Q3 2024 Portfolio in Review
As of Q3 2024, Michael Gelband held 2,213 positions worth $16.4B, up 12% from $14.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Michael Gelband deployed $963M of net new capital in Q3 2024, opening 752 new positions and adding to 404 existing holdings. Its largest new stake was Mondelez International: 1,784,906 shares worth $131M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 10% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was ConocoPhillips, an estimated $73.6M trimmed.
- Michael Gelband's largest Q3 2024 buy was Mondelez International: 1,784,906 shares worth $131M.
- Michael Gelband added most to Microsoft in Q3 2024, an estimated $384M increase.
- Michael Gelband's biggest Q3 2024 reduction was ConocoPhillips, cutting an estimated $73.6M.
- Michael Gelband fully exited Amazon in Q3 2024, selling an estimated $276M.
- Michael Gelband's ten largest holdings make up 37% of its $16.4B portfolio in Q3 2024.
- Michael Gelband opened 752 new positions and closed 645 in Q3 2024.
- Michael Gelband's portfolio value rose 12% quarter-over-quarter to $16.4B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.